CVS Health Management
Management criteria checks 3/4
CVS Health's CEO is Karen Lynch, appointed in Feb 2021, has a tenure of 3.58 years. total yearly compensation is $21.62M, comprised of 6.9% salary and 93.1% bonuses, including company stock and options. directly owns 0.04% of the company’s shares, worth $29.10M. The average tenure of the management team and the board of directors is 2.5 years and 6.6 years respectively.
Key information
Karen Lynch
Chief executive officer
US$21.6m
Total compensation
| CEO salary percentage | 6.9% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.04% |
| Management average tenure | 2.5yrs |
| Board average tenure | 6.6yrs |
Recent management updates
Recent updates
CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08
CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$7b |
| Mar 31 2024 | n/a | n/a | US$7b |
| Dec 31 2023 | US$22m | US$2m | US$8b |
| Sep 30 2023 | n/a | n/a | US$9b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$21m | US$1m | US$4b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$8b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$20m | US$1m | US$8b |
| Sep 30 2021 | n/a | n/a | US$8b |
| Jun 30 2021 | n/a | n/a | US$7b |
| Mar 31 2021 | n/a | n/a | US$7b |
| Dec 31 2020 | US$11m | US$1m | US$7b |
Compensation vs Market: Karen's total compensation ($USD21.62M) is above average for companies of similar size in the US market ($USD13.02M).
Compensation vs Earnings: Karen's compensation has been consistent with company performance over the past year.
CEO
Karen Lynch (61 yo)
3.6yrs
Tenure
US$21,615,034
Compensation
Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.6yrs | US$21.62m | 0.040% $ 29.1m | |
| Executive VP & CFO | less than a year | US$4.58m | 0.0028% $ 2.0m | |
| Executive VP of Ventures and Chief Digital | 2.2yrs | US$8.88m | 0.0032% $ 2.3m | |
| Executive VP | 1.6yrs | US$11.89m | 0.00078% $ 564.3k | |
| Executive VP | 2.8yrs | US$8.58m | 0.0037% $ 2.7m | |
| Senior Director of Business Development & CVS Health and Partner & Co-Founder | no data | no data | no data | |
| Senior VP | 5.8yrs | no data | 0.00067% $ 484.7k | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP & Chief People Officer | no data | no data | no data | |
| Executive Vice President & President of CVS Caremark | 1.7yrs | no data | 0.0032% $ 2.3m | |
| Executive VP and Chief Customer & Experience Officer | 3.7yrs | no data | 0.0099% $ 7.2m | |
| VP & Chief Health Equity Officer | 2.9yrs | no data | no data |
2.5yrs
Average Tenure
57yo
Average Age
Experienced Management: CVS's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.6yrs | US$21.62m | 0.040% $ 29.1m | |
| Independent Director | less than a year | US$195.42k | 0.00045% $ 325.6k | |
| Independent Chairman | 5.8yrs | US$576.50k | 0.00033% $ 238.7k | |
| Independent Director | 7.3yrs | US$301.50k | 0.00094% $ 680.1k | |
| Independent Director | 11yrs | US$321.50k | 0.0025% $ 1.8m | |
| Independent Director | 13.7yrs | US$321.50k | 0.0026% $ 1.9m | |
| Independent Director | 17.5yrs | US$321.50k | 0.0097% $ 7.0m | |
| Independent Director | 17.5yrs | US$321.50k | 0.0088% $ 6.3m | |
| Independent Director | 9.5yrs | US$301.50k | 0.00024% $ 173.6k | |
| Independent Director | 5.8yrs | US$318.17k | 0.0028% $ 2.0m | |
| Independent Director | 2yrs | US$301.50k | 0.00058% $ 419.6k | |
| Independent Director | less than a year | US$167.50k | 0.0011% $ 781.3k |
6.6yrs
Average Tenure
67.5yo
Average Age
Experienced Board: CVS's board of directors are considered experienced (6.6 years average tenure).